• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用共聚维酮作为造粒助剂替代微晶纤维素:对颗粒特性的影响。

Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.

机构信息

Rottendorf Pharma GmbH, Ennigerloh, Germany.

出版信息

Drug Dev Ind Pharm. 2009 Nov;35(11):1325-32. doi: 10.3109/03639040902902401.

DOI:10.3109/03639040902902401
PMID:19832632
Abstract

BACKGROUND

Microcrystalline cellulose (MCC) is the most important pelletization aid in extrusion/spheronization. Because of known disadvantages, the search for substitutes is ongoing. In this context, crospovidone has proven to offer substantial advantages as pelletization aid because of its ability to turn low-soluble active ingredients into fast-dissolving stable pellets.

METHOD

Pellets from crospovidone with different amounts of paracetamol, hydrochlorothiazide, and spironolactone as model drugs were prepared by extrusion/spheronization. For comparison, pellets with MCC as extrusion aid were also produced. The pellets of different formulations were evaluated in terms of yield, aspect ratio, mean Feret diameter, 10% interval fraction, tensile strength, disintegration, and drug release profile.

RESULTS

Only crospovidone types exhibiting small particle sizes are suitable as pelletization aid. While maintaining the pharmaceutical quality aspects, it was possible to incorporate up to 60% (w/w) active pharmaceutical ingredients (API) into pellets with crospovidone. The most distinguished differences between pellets based on crospovidone and MCC are the disintegration and drug release behavior. The pellets containing binary mixtures of the low-soluble APIs and crospovidone resulted in fast release in contrast to the pellets with MCC as pelletization aid, which exhibited a slow release.

CONCLUSION

Crospovidone shows an excellent behavior as pelletization aid and produces fast-releasing pellets even with low-soluble APIs.

摘要

背景

微晶纤维素(MCC)是挤出/滚圆中最重要的制粒助剂。由于已知的缺点,人们一直在寻找替代品。在这种情况下,交联聚维酮已被证明作为制粒助剂具有很大的优势,因为它能够将低溶性的活性成分转化为快速溶解的稳定颗粒。

方法

用不同量的对乙酰氨基酚、氢氯噻嗪和螺内酯作为模型药物的交联聚维酮颗粒通过挤出/滚圆法制备。为了进行比较,也制备了以 MCC 作为挤出助剂的颗粒。通过收率、长径比、平均 Feret 直径、10%间隔分数、拉伸强度、崩解和药物释放曲线对不同配方的颗粒进行了评估。

结果

只有表现出小粒径的交联聚维酮类型才适合作为制粒助剂。在保持药物质量方面的同时,有可能将高达 60%(w/w)的活性药物成分(API)掺入到交联聚维酮颗粒中。基于交联聚维酮和 MCC 的颗粒之间最显著的区别是崩解和药物释放行为。含有低溶性 API 和交联聚维酮的二元混合物的颗粒与 MCC 作为制粒助剂的颗粒相比,表现出快速释放,而 MCC 作为制粒助剂的颗粒则表现出缓慢释放。

结论

交联聚维酮作为制粒助剂表现出优异的性能,即使使用低溶性 API 也能产生快速释放的颗粒。

相似文献

1
Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.使用共聚维酮作为造粒助剂替代微晶纤维素:对颗粒特性的影响。
Drug Dev Ind Pharm. 2009 Nov;35(11):1325-32. doi: 10.3109/03639040902902401.
2
Influence of MCC II fraction and storage conditions on pellet properties.MCC II 级分和储存条件对颗粒性质的影响。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1039-45. doi: 10.1016/j.ejpb.2013.07.001. Epub 2013 Jul 17.
3
Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose.交联聚乙烯吡咯烷酮作为球形化助剂的功能:微晶纤维素的一种有前景的替代品。
Pharm Res. 2005 Aug;22(8):1387-98. doi: 10.1007/s11095-005-5279-3. Epub 2005 Aug 3.
4
Insights into the functionality of pelletization aid in pelletization by extrusion-spheronization.深入了解挤出造球过程中制粒助剂的功能。
Pharm Dev Technol. 2013 Feb;18(1):61-72. doi: 10.3109/10837450.2011.621210. Epub 2011 Oct 8.
5
Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.κ-卡拉胶作为微晶纤维素在挤出/滚圆法中替代制粒助剂的应用。II. 药物和填充剂类型的影响。
Eur J Pharm Biopharm. 2006 May;63(1):68-75. doi: 10.1016/j.ejpb.2005.10.003. Epub 2005 Dec 1.
6
Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.κ-卡拉胶作为微晶纤维素在挤出/滚圆造粒法中的替代制粒助剂的应用。I. 填料类型和比例的影响
Eur J Pharm Biopharm. 2006 May;63(1):59-67. doi: 10.1016/j.ejpb.2005.10.002. Epub 2005 Dec 2.
7
Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.壳聚糖-海藻酸盐作为微晶纤维素在挤出/滚圆法中替代制粒助剂的应用。
J Pharm Sci. 2007 Sep;96(9):2469-84. doi: 10.1002/jps.20855.
8
Use of extrusion aids for successful production of Kollidon CL-SF pellets by extrusion-spheronization.挤出助剂在挤出滚圆法制备交聚维酮 Kollidon® CL-SF 丸中的应用。
Drug Dev Ind Pharm. 2018 Apr;44(4):632-642. doi: 10.1080/03639045.2017.1405975. Epub 2017 Dec 7.
9
Influence of starting material particle size on pellet surface roughness.起始物料粒径对颗粒表面粗糙度的影响。
AAPS PharmSciTech. 2014 Feb;15(1):131-9. doi: 10.1208/s12249-013-0031-5. Epub 2013 Nov 6.
10
Approaches to developing fast release pellets via wet extrusion-spheronization.通过湿挤压造粒法开发快速释放丸剂的方法。
Pharm Dev Technol. 2018 Jun;23(5):432-441. doi: 10.1080/10837450.2016.1265556. Epub 2016 Dec 9.

引用本文的文献

1
Croscarmellose Sodium as Pelletization Aid in Extrusion-Spheronization.交联羧甲纤维素钠作为挤出滚圆制粒中的助流剂。
AAPS PharmSciTech. 2024 Jun 27;25(6):147. doi: 10.1208/s12249-024-02864-0.
2
MUPS Tableting-Comparison between Crospovidone and Microcrystalline Cellulose Core Pellets.微晶纤维素核丸剂与交联聚维酮的胃溶型药用辅料片压制比较
Pharmaceutics. 2022 Dec 15;14(12):2812. doi: 10.3390/pharmaceutics14122812.
3
Quality aspects in the development of pelletized dosage forms.颗粒剂剂型开发中的质量因素。
Heliyon. 2022 Feb 15;8(2):e08956. doi: 10.1016/j.heliyon.2022.e08956. eCollection 2022 Feb.
4
Formulation Development of Mucoadhesive Microparticle-Laden Gels for Oral Mucositis: An In Vitro and In Vivo Study.用于口腔黏膜炎的载有黏膜黏附性微粒的凝胶制剂研发:一项体外和体内研究
Pharmaceutics. 2020 Jun 29;12(7):603. doi: 10.3390/pharmaceutics12070603.
5
A Quality by Experimental Design Approach to Assess the Effect of Formulation and Process Variables on the Extrusion and Spheronization of Drug-Loaded Pellets Containing Polyplasdone® XL-10.一种采用实验设计方法评估制剂和工艺变量对含聚维酮XL - 10的载药微丸挤出和滚圆效果的质量研究
AAPS PharmSciTech. 2016 Apr;17(2):368-79. doi: 10.1208/s12249-015-0345-6. Epub 2015 Jul 14.
6
Influence of starting material particle size on pellet surface roughness.起始物料粒径对颗粒表面粗糙度的影响。
AAPS PharmSciTech. 2014 Feb;15(1):131-9. doi: 10.1208/s12249-013-0031-5. Epub 2013 Nov 6.
7
Importance of wet packability of component particles in pellet formation.组分颗粒的湿可压性在颗粒成型中的重要性。
AAPS PharmSciTech. 2013 Sep;14(3):1267-77. doi: 10.1208/s12249-013-0022-6. Epub 2013 Aug 17.